骨髓氧化酶作为COPD中的生物标志物
A Rekha1, Gaurav Gupta2, Pareshkumar N Patel3
1Dr.D.Y.Patil Medical College, Hospital and Research Centre, Pimpri, Pune, India.
Clinica chimica acta; international journal of clinical chemistry
|December 21, 2025
概括
骨髓氧化酶 (MPO) 是慢性阻塞性肺病 (COPD) 炎症的有前途的生物标志物,与疾病严重程度相关. 然而,为了可靠的临床使用,需要标准化检测和验证的矩阵,如血.
科学领域:
- 肺部医学 肺部医学
- 生物标志物研究 生物标志物研究
- 炎症研究 炎症研究
背景情况:
- 慢性炎症和氧化应激是COPD的关键因素,涉及中性粒细胞.
- 骨髓氧化酶 (MPO) 是一种来自中性粒细胞的酶,在这些过程中发挥作用,是潜在的生物标志物.
- 在COPD患者和吸烟者中观察到较高的MPO水平,这与中性恋负荷和疾病严重程度有关.
研究的目的:
- 批判性地审查骨髓氧化酶 (MPO) 作为慢性阻塞性肺病 (COPD) 生物标志物的生物潜力,分析方法和临床实用性.
- 评估MPO水平与中性友炎炎症,氧化损伤和COPD中的气流阻塞的相关性.
- 评估MPO临床翻译所面临的挑战和要求.
主要方法:
- 对COPD中MPO现有文献的审查.
- 在各种生物矩阵 (血清,血,唾液,EBC) 中分析MPO测量方法.
- 评估分析前的变化及其对MPO测量的影响.
主要成果:
- MPO可以在血清,血,唾液和呼出的呼吸凝析物 (EBC) 中测量.
- 存在显著的分析前变异性,特别是在血清和血MPO水平之间,血可能更准确.
- 在COPD炎症内型和风险分层的多标志物小组中,MPO显示了潜在的潜力.
结论:
- 作为COPD中中性粒细胞介导炎症的生物标志物,MPO在生物学上是合理的.
- 临床应用受到缺乏标准化试验和协调结果的限制.
- 进一步验证矩阵 (血与血清) 和整合到复合生物标志物方法是必要的临床翻译.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700